福他替尼二鈉鹽|T2605|TargetMol

價(jià)格	詢價(jià)
包裝	1removed

最小起訂量	1removed
發(fā)貨地	上海
更新日期	2026-04-02

QQ交談微信洽談

產(chǎn)品詳情

中文名稱:福他替尼二鈉鹽	英文名稱:Fostamatinib Disodium
CAS:1025687-58-4	品牌: TargetMol
產(chǎn)地: 美國	保存條件: Keep away from moisture,Store at low temperature Powder: -20°C for 3 years \| In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
純度規(guī)格: 99.09%	產(chǎn)品類別: 抑制劑
貨號: T2605

Product Introduction

Bioactivity

名稱	Fostamatinib Disodium
描述	Fostamatinib Disodium (R788 Disodium) is an orally available Syk kinase inhibitor with potential anti-inflammatory and immunomodulating activities.
細(xì)胞實(shí)驗(yàn)	Cells are exposed to increasing concentrations of R406 (in vitro active form of R935788) for 48 hours. The percentage of apoptotic cells is determined by double staining with propidium iodide (PI) and annexin-A5–FITC conjugate. Ki-67 staining is performed with the FITC mouse anti–Ki-67 set. Samples are analyzed on a FACSCalibur flow cytometer with CellQuest Version 3.3 software. (Only for Reference)
激酶實(shí)驗(yàn)	In vitro fluorescence polarization kinase assays: R406 (in vitro active form of R935788) is serially diluted in DMSO and then diluted to 1% DMSO in kinase buffer (20 mM HEPES, pH 7.4, 5 mM MgCl2, 2 mM MnCl2, 1 mM DTT, 0.1 mg/mL acetylated BGG). ATP and substrate in kinase buffer are added at room temperature, resulting in a final DMSO concentration on 0.2%. The kinase reactions are performed in a final volume of 20 μL containing 5 μM HS1 peptide substrate and 4 μM ATP and started by addition of 0.125 ng of Syk in kinase buffer. The reaction is allowed to proceed for 40 minutes at room temperature. The reaction is stopped by the addition of 20 μL of PTK quench mix containing EDTA/anti-phosphotyrosine antibody (1× final)/fluorescent phosphopeptide tracer (0.5× final) diluted in FP Dilution Buffer. The plate is incubated for 30 minutes in the dark at room temperature and then read on a Polarion fluorescence polarization plate reader. Data is converted to determine the amount of phosphopeptide present using a calibration curve generated by competition with the phosphopeptide competitor provided in the Tyrosine Kinase Assay Kit. For IC50 determination, R406 is tested at eleven concentrations in duplicate and curve-fitting is performed by non-linear regression analysis using Prism GraphPad Software.
體外活性	在小鼠腫瘤模型中,每天R935788（80 mg/kg）能夠有效抑制 TCL1-002, TCL1-551 和 TCL1-870腫瘤生長.在Eμ-TCL1轉(zhuǎn)基因小鼠中,R935788通過阻止抗原依賴性B細(xì)胞受體的信號,抑制白血病細(xì)胞增殖和存活.
體內(nèi)活性	在多種彌散性大B細(xì)胞淋巴瘤細(xì)胞系中（EC50=0.8-8.1 μM）,R406降低BLNK, Akt, GSK-3, FOXO和ERK 磷酸化,抑制細(xì)胞增殖。
存儲條件	Keep away from moisture,Store at low temperature Powder: -20°C for 3 years \| In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
溶解度	Ethanol : < 1 mg/mL (insoluble or slightly soluble) H2O : < 1 mg/mL (insoluble or slightly soluble) 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (3.2 mM), Sonication is recommended. DMSO : 50 mg/mL (80.07 mM), Sonication is recommended.
關(guān)鍵字	Syk \| Spleen tyrosine kinase \| R788 (Fostamatinib) \| R-788 \| R788 \| R 788 \| Inhibitor \| inhibit \| Fostamatinib Disodium \| Fostamatinib \| Fms like tyrosine kinase 3 \| FLT3 \| Cluster of differentiation antigen 135 \| CD135
相關(guān)產(chǎn)品	Onatasertib \| Gilteritinib \| Fostamatinib \| ANTHRAQUINONE-2-CARBOXYLIC ACID \| Ellagic acid \| Quizartinib \| Nintedanib \| Sorafenib \| Pexidartinib \| Sunitinib \| Brigatinib \| Ripretinib
相關(guān)庫	抑制劑庫 \| 抗癌上市藥物庫 \| 已知活性化合物庫 \| 激酶抑制劑庫 \| FDA 上市藥物庫 \| 抗病毒庫 \| 免疫/炎癥分子化合物庫 \| 膜蛋白靶向化合物庫 \| FDA 上市激酶抑制劑庫 \| 酪氨酸激酶分子庫 \| 藥物功能重定位化合物庫 \| 抗癌臨床化合物庫

關(guān)鍵字：福他替尼二鈉鹽|||Tamatinib Fosdium|||R788(Disodium)|||R788 Disodium|||R788 (Fostamatinib) Disodium|TargetMol

公司簡介

TargetMol Chemicals Inc. 總部位于馬薩諸塞州波士頓，致力于為全球生化領(lǐng)域科學(xué)家的研究提供專業(yè)的產(chǎn)品和服務(wù)。TargetMol?品牌的客戶群分布于40多個(gè)國家和地區(qū)，已發(fā)展成為全球知名的化合物庫和小分子化合物研究供應(yīng)商。 TargetMol?可提供160多種滿足不同需求的化合物庫，以及多種類型的生化試劑產(chǎn)品，包括12000多種抑制劑、16000多種天然產(chǎn)物和各類多肽、抗體、生命科學(xué)試劑盒等，此外，我們還建設(shè)有CADD（計(jì)算機(jī)輔助藥物設(shè)計(jì)）研究中心、藥理實(shí)驗(yàn)室、藥化合成平臺三大技術(shù)中心，全方位滿足客戶的定制需求。憑借我們優(yōu)質(zhì)的產(chǎn)品和服務(wù)、快速高效的全球供應(yīng)鏈和專業(yè)的技術(shù)支持，我們將有效幫助您縮短研發(fā)周期，取得更成功的結(jié)果。

成立日期	2013-04-18 （14年）	注冊資本	566.265100萬人民幣
員工人數(shù)	100-500人	年?duì)I業(yè)額	￥ 1億以上
主營行業(yè)	天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù)	經(jīng)營模式	貿(mào)易,工廠,試劑,定制,服務(wù)

TargetMol中國（陶術(shù)生物）

VIP 5年

公司成立：14年
注冊資本：566.265100萬人民幣
企業(yè)類型：有限責(zé)任公司(自然人投資或控股)
主營產(chǎn)品：小分子抑制劑、藥物篩選化合物庫、藥物篩選等
公司地址：靜安區(qū)江場三路238號8樓

進(jìn)入店鋪

詢盤

店內(nèi)推薦

化合物 IRL 2500|T15596|TargetMol

￥215

布舍瑞林|TP1307|TargetMol

￥337

化合物 Ubrogepant|T17194|TargetMol

￥1330